Fever News and Research

RSS

Study finds link between acetaminophen use during pregnancy and language delays in children

Acetaminophen is considered the safest over-the-counter pain reliever and fever reducer available during pregnancy.

3 Jan 2024

Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

26 Dec 2023

UKHSA announces concerning rise in antibiotic-resistant Shigella cases

There has been a concerning rise in cases of extensively antibiotic-resistant Shigella sonnei infections, mainly in gay, bisexual, and other men who have sex with men (GBMSM), UKHSA has announced.

21 Dec 2023

Digital health algorithm drastically cuts antibiotic use in Tanzanian children

A Nature Medicine study shows that the ePOCT+ digital health algorithm significantly reduces antibiotic prescriptions in children under 15 in Tanzania, highlighting its potential in combating antimicrobial resistance.

20 Dec 2023

Autopsy study provides new insights into yellow fever's impact on the heart

To fill gaps in knowledge of yellow fever (YF), a group of researchers in Brazil affiliated with the Department of Pathology at the University of São Paulo's Medical School (FM-USP), Hospital das Clínicas (HC, the hospital complex run by FM-USP), the Heart Institute (InCor, linked to HC) and Emílio Ribas Institute of Infectious Diseases (IIER) decided to study the pathogenesis of YF-associated heart injury.

19 Dec 2023

Two proteins in the blood could predict dengue severity

Scientists and clinicians at Nanyang Technological University, Singapore (NTU Singapore) and the National Centre for Infectious Diseases (NCID) have identified two compounds - sST2 and suPAR - in the blood of dengue patients that could determine if a patient is at risk of severe dengue in the early phases of the disease.

18 Dec 2023

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

15 Dec 2023

Study exposes racial disparities in Lyme disease diagnosis and treatment times

Study reveals racial disparities in Lyme disease diagnosis and treatment, with Black patients experiencing longer delays and higher risks of disseminated disease compared to White patients.

14 Dec 2023

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

13 Dec 2023

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

This study in Scientific Reports reveals that symptoms of community-acquired bacterial meningitis (CABM) vary between children and adults, emphasizing the need for tailored approaches in early diagnosis and treatment to improve outcomes.

10 Dec 2023

Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability

Viruses have limited genetic material-;and few proteins-;so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.

8 Dec 2023

Simple screening tool reveals the prevalence of malnutrition among patients at UNC’s IBD clinic

Eating food and absorbing its nutrients is an everyday occurrence, but this normal activity can look different for someone who suffers from inflammatory bowel disease.

8 Dec 2023

Omicron infection linked to brain structure changes in men, study finds

Study reveals that men infected with the SARS-CoV-2 Omicron variant experience changes in brain structure, including reduced gray matter thickness and subcortical nuclear volume. These findings, based on MRI data and clinical symptoms, highlight the neurological impact of Omicron infection, contributing to our understanding of COVID-19's effects on the brain.

4 Dec 2023

Needle-free vaccine patch can protect people from deadly Zika virus

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

30 Nov 2023

Lyme disease aftercare: new insights into persistent symptoms

Study explores the causes of persistent symptoms after Lyme borreliosis (LB) treatment, revealing that factors like social and physical functioning, psychological distress, and comorbidities are key determinants.

29 Nov 2023

Portable AI-driven COVID-19 test detects variants with high accuracy

A new AI-assisted molecular diagnostic platform capable of identifying variants of COVID-19 and other infectious diseases has been developed by scientists in the UK. The low cost, portable device could play a crucial role in preventing future pandemics due to its accuracy and versatility.

29 Nov 2023

Researchers develop a new early alert model for pandemic predictions in Germany

An early alert indicator and trend forecasting model for pandemic situations in Germany.

29 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Plant proteins found to mimic human immune signaling proteins

Researchers have shown that certain plant proteins resemble human signaling proteins of the immune system and can bind to their receptors.

23 Nov 2023

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Fever News and Research

Study finds link between acetaminophen use during pregnancy and language delays in children

Researchers receive two grants to study tuberculosis drug development

UKHSA announces concerning rise in antibiotic-resistant Shigella cases

Digital health algorithm drastically cuts antibiotic use in Tanzanian children

Autopsy study provides new insights into yellow fever's impact on the heart

Two proteins in the blood could predict dengue severity

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study exposes racial disparities in Lyme disease diagnosis and treatment times

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability

Simple screening tool reveals the prevalence of malnutrition among patients at UNC’s IBD clinic

Omicron infection linked to brain structure changes in men, study finds

Needle-free vaccine patch can protect people from deadly Zika virus

Lyme disease aftercare: new insights into persistent symptoms

Portable AI-driven COVID-19 test detects variants with high accuracy

Researchers develop a new early alert model for pandemic predictions in Germany

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Plant proteins found to mimic human immune signaling proteins

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News